GlassScriptPhysician profile
Stephen Allen Rodes
NPI 1912174889
$1,806.51
in general payments reported to CMS, 2019-2025
15 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,174 · 2020: $188 · 2021: $19.17 · 2022: $87.54 · 2024: $190 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $458.98 | 2019-2020 | |
| Stryker Corporation | $345.43 | 2019-2025 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation, Gamma |
| Alpha Orthopedic Systems | $230.82 | 2019 | |
| Depuy Synthes Sales INC. | $147.64 | 2019 | |
| Ferring Pharmaceuticals INC. | $133.59 | 2019-2022 | |
| Vericel Corporation | $119.03 | 2019 | |
| Mimedx Group, INC. | $101.82 | 2024 | |
| Pacira Therapeutics, INC. | $91.29 | 2019-2020 | |
| Bioventus LLC | $41.41 | 2019 | |
| Baxter Healthcare | $34.17 | 2025 | |
| Innovation Technologies INC | $23.07 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.94 | 2022 | |
| Biocomposites INC | $19.17 | 2021 | |
| Horizon Therapeutics Plc | $19.10 | 2019 | |
| Arthrosurface Incorporated | $19.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Rodes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.